by Stacey Johnson | Jun 7, 2019
Australian culture and pride were very much on display at ISCT 2019, the annual meeting of clinicians, regulators, researchers, technologists and industry who claim membership in the International Society for Cell and Gene Therapy (ISCT). While it was my first time...
by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
Comments